Lithium Ion

Lithium Ion

SCHEMBL4007958

COC1CN(c2ncnc3c2c(-c2ccccc2Cl)cn3CC(=O)[O-])C1.[Li+]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.38
TP53 P04637 3/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PDE2A O00408 2/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
CNR1 P21554 6/20 0.34
CNR2 P34972 5/20 0.34
LRRK2 Q5S007 1/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4007954 0.90 MAPT (0.40) MAPTTP53POLBKDM4EMEN1
Lithium SCHEMBL4007964 0.90 MAPT (0.40) MAPTTP53POLBKDM4EMEN1
SCHEMBL4013415 0.79 LMNA (0.39) MAPTTP53POLBKDM4EMEN1
SCHEMBL4010459 0.79 MAPT (0.41) MAPTTP53POLBKDM4EMEN1
SCHEMBL13770196 0.78 MAPT (0.44) MAPTTP53POLBKDM4EMEN1
SCHEMBL13769533 0.78 MAPT (0.44) MAPTTP53POLBKDM4EMEN1
SCHEMBL13769983 0.76 CALCRL (0.41)
SCHEMBL13769972 0.75 SCD (0.36) MAPTTP53CNR1CNR2
SCHEMBL4007937 0.75 CALCRL (0.53) PDE2APDE10A
SCHEMBL4006053 0.75 LMNA (0.47) MAPTTP53POLBKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080682-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2009-07-02 WO disclosed